stockrowBioStem Technologies, Inc. (BSEM) vs Seres Therapeutics, Inc. (MCRB)
- BioStem Technologies, Inc. BSEM 1.12 +7.69%
- Seres Therapeutics, Inc. MCRB 1.97 −5.74%
BioStem Technologies, Inc. and Seres Therapeutics, Inc. are both Biotechnology companies. BioStem Technologies, Inc. and Seres Therapeutics, Inc. are of similar size ($20.8M and $19.4M). BioStem Technologies, Inc. grew revenue faster over the last twelve months: −87.1% against −98.3%. BioStem Technologies, Inc. has the higher net margin (−76.0% vs −2,209.6%) and the higher return on invested capital (55.3% vs −1,267.8%). Across the 16 metrics below, BioStem Technologies, Inc. leads on 13 and Seres Therapeutics, Inc. on 3.
Valuation
Profitability
| Metric | BSEM | MCRB | Biotechnology median |
|---|---|---|---|
| Gross margin | 91.16% | 100.00% | 68.51% |
| Operating margin | 52.87% | (3,656.89%) | 0.00% |
| Net margin | (76.02%) | (2,209.55%) | 0.00% |
| Free cash flow margin | 0.00% | (2,997.74%) | 0.00% |
| Return on equity | 0.00% | (144.35%) | (51.96%) |
| Return on assets | 0.00% | (44.85%) | (46.06%) |
| Return on invested capital | 55.34% | (1,267.77%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack